Stock listing

LS Exchange:A14156 LivaNova PLC Aktie

German listing (LS Exchange) of LivaNova PLC · home listing NASDAQ:LIVN

Follow LivaNova PLC into a list and get an email when it puts out news.

Home listing price · NASDAQ:LIVN

$90.73 USD -3.81 (-4.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LIVN

Past year +69.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$90.15 – $93.16 USDNov 20, 2026
Volume
536,657 sharesNov 20, 2026
Market cap
$5.00B USDAt the close on Nov 20, 2026 · price × 55.09M shares outstanding
52-week range
$53.48 – $99.38 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$56.25M USDMedian day 579,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
LivaNova PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LIVN · Home$90.73 USD-3.81 (-4.0%)536,657$91.61$93.16$90.15$94.54Close on Nov 20, 2026
Frankfurt:LIA€83.50 EUR-4.00 (-4.6%)—€83.50€83.50€83.50€87.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LIVN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$90.73-3.81-4.0%$91.61$93.16$90.15536,657
$94.54+2.62+2.9%$91.29$95.40$90.201,321,127
$91.92-0.52-0.6%$92.73$93.64$91.63573,603
$92.44+1.12+1.2%$90.77$94.80$90.77805,674
$91.32+1.12+1.2%$90.47$92.31$88.63742,275
$90.20-0.78-0.9%$90.91$91.32$89.88465,909
$90.98-0.16-0.2%$90.58$91.54$90.24652,684
$91.14-1.47-1.6%$91.63$92.00$89.33754,133
$92.61+2.62+2.9%$92.00$93.25$91.11628,608
$89.99-1.15-1.3%$90.09$91.51$88.42443,974
$91.14-3.05-3.2%$93.77$94.22$88.811,242,578
$94.19+14.29+17.9%$89.68$99.38$89.503,788,870
$79.90-0.31-0.4%$80.40$81.87$79.56946,612
$80.21+1.24+1.6%$79.80$82.03$78.85605,522
$78.97-2.28-2.8%$81.38$82.87$78.41575,594
$81.25+0.59+0.7%$81.92$82.28$81.05483,270
$80.66+0.28+0.3%$79.88$81.92$79.88550,582
$80.38-0.24-0.3%$81.04$81.04$80.05383,596
$80.62-0.28-0.3%$80.90$81.58$79.68362,373
$80.90-0.37-0.5%$80.72$81.77$80.33572,100
$81.27+2.83+3.6%$78.70$81.42$78.35523,000
$78.44-1.27-1.6%$79.83$81.25$78.01556,300
$79.71+1.57+2.0%$78.86$80.69$78.85583,800
$78.14+0.56+0.7%$78.02$78.84$77.39387,100
$77.58-0.92-1.2%$78.69$79.31$77.18774,000
$78.50+2.42+3.2%$76.90$79.11$76.20738,000
$76.08-0.29-0.4%$75.82$77.28$75.13464,600
$76.37-0.90-1.2%$77.34$78.10$76.12561,300
$77.27+0.88+1.2%$76.12$77.35$75.991,029,600
$76.39+0.48+0.6%$76.12$77.66$75.63339,400
$75.91-0.020.0%$75.45$76.25$74.23467,200
$75.93+1.00+1.3%$75.06$76.26$74.44692,100
$74.93-1.50-2.0%$76.80$76.80$74.58424,500
$76.43+1.36+1.8%$75.56$76.90$74.23558,900
$75.07+0.37+0.5%$75.68$76.77$74.64528,500
$74.70-1.80-2.4%$76.44$77.15$74.47767,200
$76.50-0.49-0.6%$77.11$77.11$75.40970,700
$76.99-0.22-0.3%$76.71$77.15$76.13567,800
$77.21+0.58+0.8%$76.13$77.66$75.47570,700
$76.63+1.19+1.6%$75.44$77.46$75.12745,300
$75.44-1.72-2.2%$77.26$77.45$74.111,056,400
$77.16-1.33-1.7%$78.39$79.02$76.70493,100
$78.49+0.32+0.4%$79.19$80.19$78.18640,500
$78.17+0.16+0.2%$78.39$78.63$76.83579,200
$78.01+0.22+0.3%$77.34$78.44$76.781,377,500
$77.79-0.72-0.9%$79.23$79.23$77.51627,300
$78.51-0.96-1.2%$79.56$80.63$77.69693,600
$79.47-1.16-1.4%$80.19$80.24$79.13587,200
$80.63+2.45+3.1%$78.70$80.77$78.30552,000
$78.180.000.0%$79.22$79.27$77.15552,400
$78.18-0.75-1.0%$78.11$78.88$77.37425,900
$78.93-1.77-2.2%$80.22$80.37$78.11674,400
$80.70-1.22-1.5%$81.44$81.83$80.16473,000
$81.92+0.72+0.9%$80.67$82.22$80.39334,200
$81.20-1.20-1.5%$83.50$83.52$80.81694,100
$82.40+2.24+2.8%$80.16$83.32$80.16769,400
$80.16+0.35+0.4%$79.57$80.63$78.49585,400
$79.81-0.51-0.6%$79.86$80.15$77.28593,700
$80.32+0.29+0.4%$80.10$80.77$79.43466,000
$80.03+0.06+0.1%$79.34$80.27$78.96611,300
$79.97+0.56+0.7%$79.83$80.03$77.63733,400
$79.41+1.15+1.5%$78.73$79.59$77.90562,919
$78.26-0.48-0.6%$78.65$80.00$78.00823,214
$78.74+0.53+0.7%$78.80$79.56$77.94440,200
$78.21-2.63-3.3%$80.00$80.81$77.90418,800
Ticker
LS Exchange:A14156
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All LivaNova PLC news

LivaNova PLC on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
24 in the last 12 months · 168 in all · newest Nov 4, 2026 · oldest 2019
Calls
24 calls with a replay · 24 with a transcript · latest Nov 4, 2026
Decks
39 decks · latest Nov 4, 2026

Where LivaNova PLC is listed

ListingExchangeCountryCurrency
NASDAQ:LIVN · Home listingNASDAQUnited StatesUSD
Tradegate:LIATradegateGermanyEUR
LS Exchange:A14156 · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A14156Lang & SchwarzGermanyEUR
gettex:LIAgettexGermanyEUR
BOATS:LIVNBOATSUnited StatesUSD
B3:L2IV34B3BrazilBRL
Frankfurt:LIAFrankfurtGermanyEUR
Dusseldorf:LIADusseldorfGermanyEUR
Munich:LIAMunichGermanyEUR
Stuttgart:LIAStuttgartGermanyEUR

Valuation

P/E 25.5× against a median of 39.3×: 3rd lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$4.73B USD
P/E
25.5×
EV/sales
3.1×
EV/EBITDA
21.6×
Price/book
3.6×
Gross margin
67.8%
Operating margin
10.8%
Net margin
13.0%
Debt to equity
0.2×
Beta vs S&P 500
1.02

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
LivaNova PLC · NASDAQ:LIVNUS$5.00BUS$4.73B25.5×3.1×21.6×3.6×13.0%0.2×1.02
ConvaTec Group PLC · LSE:CTECUS$6.64BUS$8.29B37.9×3.4×15.2×4.6×7.2%1.2×n/a
Cochlear Limited · ASX:COHUS$6.49BUS$6.51B66.6×4.2×24.2×5.6×6.3%0.1×n/a
APT Medical Inc. Class A · SSE:688617US$5.98BUS$5.72B39.3×12.4×n/a11.8×33.0%0.0×n/a
Haemonetics Corporation · NYSE:HAEUS$5.47BUS$6.35B52.7×4.6×22.1×6.1×7.5%1.3×0.27
Merit Medical Systems, Inc. · NASDAQ:MMSIUS$5.05BUS$5.29B31.6×3.3×15.4×2.9×9.9%0.4×0.49
Intco Medical Technology Co., Ltd. Class A · SZSE:300677US$4.73BUS$3.55B106×1.8×n/a1.7×2.3%0.0×n/a
MiniMed Group, Inc. · NASDAQ:MMEDUS$4.50BUS$4.30Bn/an/an/a1.2×n/a0.0×1.04
ICU Medical, Inc. · NASDAQ:ICUIUS$4.31BUS$5.16B71.5×2.4×16.6×2.0×2.8%0.5×0.99
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A · SZSE:002223US$4.18BUS$3.97B24.3×3.3×n/a2.2×14.3%0.0×n/a
IMEIK Technology Development Co., Ltd. Class A · SZSE:300896US$3.67BUS$3.13B24.8×9.0×n/a3.1×42.4%0.0×n/a
Median of the othersUS$4.89BUS$5.23B39.3×3.4×16.6×3.0×7.5%0.1×0.74

Forecasts

6 strong buy · 3 buy · 1 hold · 1 sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
106.36 USD · Analysts' mean
EPS, year to Dec 2026
4.44 · 10 analysts
Revenue, year to Dec 2026
1.53B · 10 analysts

Team and board

Officers

OfficerRole
Vladimir MakatsariaChief Executive Officer
Alex ShvartsburgChief Financial Officer
Stefano FolliPresident, Cardiopulmonary
Stephanie BoltonPresident, Global Epilepsy
Anne LiddyChief Legal Officer
Briana GotlinVice President, Investor Relations
Deanna WilkeVP, Corporate Communications
Ahmet TezelChief Innovation Officer
Lucile BlaiseGlobal Head of Commercialization, Obstructive Sleep Apnea
Natalia KozminaChief Human Resources Officer
Philip KowalczykChief Strategy and Corporate Development Officer
Sujay MashruSenior Vice President, APAC and Growth Markets

Board

DirectorRole
William KozyChair of the Board
Brooke StoryDirector since 2022
Donald ZurbayDirector since 2025
Francesco BianchiDirector since 2015
J. Christopher BarryDirector since 2023
Jette Nygaard-AndersenDirector since 2026
Peter WilverDirector since 2022
Stacy Enxing SengDirector since 2019
Susan PodlogarDirector since 2024
Todd C. SchermerhornDirector since 2020
Vladimir MakatsariaChief Executive Officer

Events

Calls

CallWhenStatus
LivaNova (NASDAQ:LIVN) Q3 2026 Earnings CallWed, Nov 04, 2026 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2026 Earnings CallWed, Aug 05, 2026 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q1 2026 Earnings CallWed, May 06, 2026 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2025 Earnings CallWed, Feb 25, 2026 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q3 2025 Earnings CallWed, Nov 05, 2025 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2025 Earnings CallWed, Aug 06, 2025 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q1 2025 Earnings CallWed, May 07, 2025 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2024 Earnings CallTue, Feb 25, 2025 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q3 2024 Earnings CallWed, Oct 30, 2024 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2024 Earnings CallWed, Jul 31, 2024 · 8:00 AM ETReplay
All 24 calls
CallWhenStatus
LivaNova (NASDAQ:LIVN) Q1 2024 Earnings CallWed, May 01, 2024 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2023 Earnings CallWed, Feb 21, 2024 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q3 2023 Earnings CallWed, Nov 01, 2023 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2023 Earnings CallWed, Jul 26, 2023 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q1 2023 Earnings CallWed, May 03, 2023 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2022 Earnings CallWed, Feb 22, 2023 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q3 2022 Earnings CallWed, Nov 02, 2022 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2022 Earnings CallWed, Aug 03, 2022 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q1 2022 Earnings CallWed, May 04, 2022 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2021 Earnings CallWed, Feb 23, 2022 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q3 2021 Earnings CallWed, Nov 03, 2021 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q2 2021 Earnings CallWed, Jul 28, 2021 · 8:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q1 2021 Earnings CallWed, Apr 28, 2021 · 7:00 AM ETReplay
LivaNova (NASDAQ:LIVN) Q4 2020 Earnings CallWed, Feb 24, 2021 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · Before open+17.9%
Q2 2026Aug 5, 2026 · Before open−8.4%
Q1 2026May 6, 2026 · Before open+15.1%
Q4 2025Feb 25, 2026+2.8%
Q3 2025Nov 5, 2025 · Before open−5.8%
Q2 2025Aug 6, 2025 · Before open+11.2%
Q1 2025May 7, 2025 · Before open+23.7%
Q4 2024Feb 19, 2025 · Before open+0.6%
Q3 2024Oct 30, 2024 · Before open−3.1%
Q2 2024Jul 31, 2024 · Before open−3.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 1, 2024 · Before open+12.3%
Q4 2023Feb 21, 2024 · Before open+8.0%
Q3 2023Nov 1, 2023 · Before open+2.0%
Q2 2023Jul 26, 2023 · Before open+9.9%
Q1 2023May 3, 2023 · Before open+0.8%
Q4 2022Feb 22, 2023 · Before open−10.9%
Q3 2022Nov 2, 2022 · Before open+3.1%
Q2 2022Aug 3, 2022 · Before open−0.5%
Q1 2022May 4, 2022 · Before open−1.0%
Q4 2021Feb 23, 2022 · Before open+1.7%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings30 slidesNov 4, 2026
Q2 2026 Earnings PresentationEarnings29 slidesAug 5, 2026
Q1 2026 Earnings PresentationEarnings26 slidesMay 6, 2026
Q4 2025 Earnings PresentationEarnings31 slidesFeb 25, 2026
Q3 2025 Earnings PresentationEarnings27 slidesNov 5, 2025
Q2 2025 Earnings PresentationEarnings29 slidesAug 6, 2025
Q1 2025 Earnings PresentationEarnings25 slidesMay 7, 2025
Q4 2024 Earnings PresentationEarnings31 slidesFeb 25, 2025
Q3 2024 Earnings PresentationEarnings26 slidesOct 30, 2024
Q2 2024 Earnings PresentationEarnings26 slidesJul 31, 2024
All 39 decks
DeckKindSlidesDate
Q1 2024 Earnings PresentationEarnings24 slidesMay 1, 2024
Q4 2023 Earnings PresentationEarnings32 slidesFeb 21, 2024
Q3 2023 Earnings PresentationEarnings27 slidesNov 1, 2023
Q2 2023 Earnings PresentationEarnings27 slidesJul 26, 2023
Q1 2023 Earnings PresentationEarnings27 slidesMay 3, 2023
Q3 2022 Earnings PresentationEarnings28 slidesNov 2, 2022
Q3 2021 Earnings PresentationEarnings24 slidesNovember 2021
Q2 2021 Earnings PresentationEarnings25 slidesJuly 2021
Q1 2021 Earnings PresentationEarnings25 slidesApr 28, 2021
Q3 2020 Earnings PresentationEarnings23 slidesOctober 2020
Q2 2020 Earnings PresentationEarnings23 slidesJul 29, 2020
Q4 2019 Earnings PresentationEarnings27 slidesFebruary 2020
Q1 2020 Earnings PresentationEarnings23 slides2020
Q3 2019 Earnings PresentationEarnings22 slidesOct 30, 2019
Q2 2019 Earnings PresentationEarnings22 slidesJul 31, 2019
Piper Jaffray 30th Annual Healthcare Conference (November 2018)Conference11 slidesNov 28, 2018
Investor Presentation (June 2018)Investor deck27 slidesJun 6, 2018
Barclays Global Healthcare Conference 2018Conference16 slidesMar 13, 2018
FY2017 Earnings PresentationEarnings30 slidesFeb 28, 2018
Berenberg European Heart Valves Conference 2017Conference27 slidesDec 6, 2017
Investor Presentation (December 2017)Investor deck41 slidesDec 5, 2017
Q3 2017 Earnings PresentationEarnings20 slidesNov 2, 2017
Investor Day (September 2017)Investor day17 slidesSep 14, 2017
Investor Day (September 2017)Investor day17 slidesSep 14, 2017
Investor Day (September 2017)Investor day19 slidesSep 14, 2017
Investor Day (September 2017)Investor day82 slidesSep 14, 2017
Investor Day (September 2017)Investor day17 slidesSep 14, 2017
Q2 2017 Earnings PresentationEarnings20 slidesAug 9, 2017
Technical PresentationTechnical138 slides

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.39B1.25B1.15B1.02B1.04B934.2M1.08B1.11B1.01B964.9M
Cost of revenue448.2M400.0M397.7M314.6M329.4M339.5M360.4M361.3M353.2M367.8M
Gross profit939.9M853.5M755.8M707.2M706.0M594.8M723.8M734.5M651.6M559.5M
Research and development185.8M182.5M193.8M155.8M183.4M152.9M146.8M145.9M109.5M82.1M
Selling, general and administrative548.8M508.9M502.7M469.2M471.9M446.6M528.5M465.0M380.1M355.2M
Operating income199.4M129.1M-68.5M-76.8M-784.0K-273.9M-171.6M-248.1M96.5M33.4M
Depreciation and amortization28.6M25.1M24.7M22.4M24.5M29.0M30.3M32.7M37.1M85.4M
EBITDA228.0M154.2M-43.8M-54.4M23.8M-244.9M-141.2M-215.3M133.5M118.8M
Interest expense49.3M63.1M58.9M48.3M50.2M40.8M15.1M9.82M7.80M10.6M
Income before tax-220.8M88.3M-81.2M-75.1M-124.5M-348.0M-188.4M-247.4M121.1M25.7M
Income tax21.6M25.1M-98.9M11.1M11.2M-960.0K-30.4M-69.6M50.0M5.11M
Net income-242.5M63.2M17.5M-86.2M-135.8M-348.8M-157.6M-189.4M-25.1M-62.8M
Earnings per share, basic-4.451.170.33-1.61-2.68-7.18-3.21-3.91-0.52-1.29
Earnings per share, diluted-4.451.160.32-1.61-2.68-7.18-3.26-3.91-0.52-1.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents635.6M428.9M266.5M214.2M208.0M252.8M61.1M47.2M93.6M39.8M
Short-term investments-34.0K-2.00K31.1M2.65M2.94M-8.00K
Receivables216.0M193.2M215.1M183.1M185.4M184.4M257.8M256.1M282.1M213.3M
Inventory164.7M147.6M147.9M129.4M105.8M115.3M164.2M153.5M144.5M133.0M
Current assets1.10B1.13B988.2M886.1M679.2M708.0M549.4M533.3M869.9M812.7M
Property, plant and equipment242.6M170.3M154.2M147.2M150.1M163.8M181.4M191.4M192.4M203.7M
Goodwill792.8M750.0M782.9M768.8M899.5M922.3M915.8M956.8M784.2M691.7M
Total assets2.61B2.51B2.43B2.29B2.20B2.40B2.41B2.55B2.50B2.34B
Accounts payable97.2M69.7M80.8M74.3M68.0M73.7M85.9M76.7M85.9M71.9M
Current liabilities808.1M392.1M335.0M297.4M697.0M309.1M512.6M496.7M406.0M349.9M
Long-term debt345.2M549.6M568.5M518.1M9.85M642.3M260.3M139.5M62.0M75.2M
Total debt376.1M627.0M586.0M539.0M236.8M650.7M333.5M162.8M87.8M149.2M
Total liabilities1.41B1.19B1.15B1.09B906.3M1.29B1.03B1.05B688.6M635.7M
Shareholders' equity1.20B1.32B1.28B1.21B1.29B1.11B1.38B1.50B1.82B1.71B
Shares outstanding54.6M54.3M53.9M53.6M53.3M48.7M48.4M48.2M48.3M48.0B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations254.3M183.0M74.9M69.9M102.5M-79.4M-91.1M120.5M91.3M90.2M
Capital spending-81.0M-47.1M-35.0M-26.5M-25.5M-35.0M-24.7M-37.2M-32.9M-38.4M
Free cash flow173.3M135.9M39.9M43.4M77.1M-114.4M-115.8M83.3M58.4M51.8M
Cash from investing-72.9M-48.2M-40.3M-38.4M36.9M-41.8M-41.3M-120.6M-52.9M-44.5M
Cash from financing-285.7M18.6M21.5M280.1M-181.5M310.8M146.6M-42.3M11.3M-118.0M
Dividends paid-4.84M00
Share buybacks-4.43M-8.44M-7.50M-8.70M-12.9M00-50.0M0-54.5M
Change in cash-88.0M145.7M62.3M307.6M-44.8M191.7M13.9M-46.4M53.8M-72.8M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 13, 2026Insider tradeSEC
144 · Notice of proposed saleNov 12, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2026Big-stake noticeSEC
IRANNOTICENov 4, 2026Other filingsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
144 · Notice of proposed saleSep 10, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 8, 2026Insider tradeSEC
144 · Notice of proposed saleSep 4, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 2, 2026Insider tradeSEC
144 · Notice of proposed saleAug 31, 2026Other filingsSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 6, 2026Big-stake noticeSEC
IRANNOTICEAug 5, 2026Other filingsSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
3 · Initial statement of ownershipAug 5, 2026Insider tradeSEC
8-K · Current reportAug 5, 2026ResultsSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
3 · Initial statement of ownershipJun 11, 2026Insider tradeSEC
8-K · Current reportJun 11, 2026Meeting outcomeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
144 · Notice of proposed saleMay 26, 2026Other filingsSEC
IRANNOTICEMay 6, 2026Other filingsSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 30, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
IRANNOTICEFeb 25, 2026Other filingsSEC
10-K · Annual reportFeb 25, 2026Annual reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
8-K · Current reportJan 14, 2026Management or board changeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2025Big-stake noticeSEC
IRANNOTICENov 5, 2025Other filingsSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 4, 2025Insider tradeSEC
8-K · Current reportSep 4, 2025Management or board changeSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
144 · Notice of proposed saleAug 25, 2025Other filingsSEC
IRANNOTICEAug 6, 2025Other filingsSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 18, 2025Big-stake noticeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
S-8 · Registration statement for employee plansJun 12, 2025Offer documentSEC
8-K · Current reportJun 11, 2025Management or board changeSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
8-K · Current reportMay 21, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 13, 2025Big-stake noticeSEC
IRANNOTICEMay 7, 2025Other filingsSEC
10-Q · Quarterly reportMay 7, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
8-K · Current reportMar 17, 2025Current reportSEC
IRANNOTICEFeb 25, 2025Other filingsSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
3 · Initial statement of ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
144 · Notice of proposed saleDec 11, 2024Other filingsSEC
144 · Notice of proposed saleDec 10, 2024Other filingsSEC
8-K · Current reportNov 1, 2024Current reportSEC
IRANNOTICEOct 30, 2024Other filingsSEC
10-Q · Quarterly reportOct 30, 2024Quarterly reportSEC
8-K · Current reportOct 30, 2024ResultsSEC
3 · Initial statement of ownershipOct 15, 2024Insider tradeSEC
8-K · Current reportOct 8, 2024Management or board changeSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
3/A · Initial statement of ownership, amendedSep 17, 2024Insider tradeSEC
4 · Change in ownershipSep 13, 2024Insider tradeSEC
144 · Notice of proposed saleSep 11, 2024Other filingsSEC
8-K · Current reportSep 10, 2024Management or board changeSEC
3 · Initial statement of ownershipAug 9, 2024Insider tradeSEC
IRANNOTICEAug 1, 2024Other filingsSEC
10-Q · Quarterly reportAug 1, 2024Quarterly reportSEC
8-K · Current reportJul 31, 2024ResultsSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
S-8 · Registration statement for employee plansJun 12, 2024Offer documentSEC
8-K · Current reportJun 12, 2024Management or board changeSEC
DEFA14A · Additional proxy materialJun 5, 2024Meeting noticeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
144 · Notice of proposed saleJun 3, 2024Other filingsSEC
SD · Specialized disclosureMay 30, 2024ESG reportSEC
3 · Initial statement of ownershipMay 17, 2024Insider tradeSEC
IRANNOTICEMay 3, 2024Other filingsSEC
10-Q · Quarterly reportMay 3, 2024Quarterly reportSEC
8-K · Current reportMay 1, 2024ResultsSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
SC 13G · Big-stake noticeApr 17, 2024Big-stake noticeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 11, 2024Insider tradeSEC
8-K · Current reportMar 8, 2024Material contractSEC
8-K · Current reportMar 5, 2024Current reportSEC
3 · Initial statement of ownershipMar 4, 2024Insider tradeSEC
4 · Change in ownershipMar 4, 2024Insider tradeSEC
8-K · Current reportMar 4, 2024Current reportSEC
IRANNOTICEFeb 29, 2024Other filingsSEC
10-K · Annual reportFeb 29, 2024Annual reportSEC
8-K · Current reportFeb 21, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
8-K · Current reportFeb 5, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJan 23, 2024Big-stake noticeSEC
8-K · Current reportJan 8, 2024Current reportSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
4 · Change in ownershipDec 19, 2023Insider tradeSEC
8-K · Current reportDec 13, 2023Current reportSEC
8-K · Current reportDec 6, 2023Current reportSEC
8-K · Current reportNov 20, 2023Current reportSEC
IRANNOTICENov 1, 2023Other filingsSEC
10-Q · Quarterly reportNov 1, 2023Quarterly reportSEC
8-K · Current reportNov 1, 2023ResultsSEC
8-K · Current reportOct 19, 2023Management or board changeSEC
4 · Change in ownershipOct 17, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 13, 2023Insider tradeSEC
8-K · Current reportOct 6, 2023Management or board changeSEC
8-K/A · Current report, amendedSep 21, 2023Management or board changeSEC
8-K · Current reportSep 21, 2023Current reportSEC
4 · Change in ownershipSep 19, 2023Insider tradeSEC
4 · Change in ownershipSep 19, 2023Insider tradeSEC
S-8 · Registration statement for employee plansJul 26, 2023Offer documentSEC

This page holds 200 of 957 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from LivaNova PLC’s releases

Common shares
55,086,809
Fully diluted
55,086,809

Fully diluted

LineShares
Common shares55,086,809

Share count over time

CountShares
Nov 22, 202655,086,809

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
Vanguard Capital Opportunity Fund1.9MUS$156MJun 30, 2026
iShares Core S&P Mid-Cap ETF1.88MUS$155MJun 30, 2026
Invesco Small Cap Value Fund1.68MUS$135MJul 31, 2026
Avantis U.S. Small Cap Value ETF1.62MUS$119MMay 31, 2026
iShares Russell 2000 ETF1.44MUS$119MJun 30, 2026
Artisan International Small-Mid Fund1.37MUS$113MJun 30, 2026
Hood River Small-Cap Growth Fund1.32MUS$108MJun 30, 2026
Fidelity Small Cap Value Fund813KUS$65.1MJul 31, 2026
PRIMECAP Odyssey Aggressive Growth Fund802KUS$64.3MJul 31, 2026
Congress Small Cap Growth Fund750KUS$60.1MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard Extended Market Index Fund630KUS$51.8MJun 30, 2026
Fidelity Small Cap Index Fund614KUS$49.2MJul 31, 2026
Vanguard Primecap Core Fund582KUS$47.9MJun 30, 2026
Fidelity Stock Selector Small Cap Fund565KUS$45.3MJul 31, 2026
iShares Russell 2000 Value ETF415KUS$34.1MJun 30, 2026
PRIMECAP Odyssey Growth Fund408KUS$32.7MJul 31, 2026
Janus Henderson Mid Cap Value Fund390KUS$32.1MJun 30, 2026
Invesco S&P MidCap Quality ETF373KUS$29.9MJul 31, 2026
Touchstone Strategic Trust-Touchstone Small Company Fund362KUS$29.7MJun 30, 2026
Vanguard Strategic Equity Fund336KUS$27.6MJun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF328KUS$27MJun 30, 2026
Fidelity Series Small Cap Opportunities Fund324KUS$26MJul 31, 2026
Fidelity Extended Market Index Fund282KUS$20.8MMay 31, 2026
Vanguard Russell 2000 Index Fund280KUS$20.7MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF278KUS$22.9MJun 30, 2026
Fidelity Small Cap Growth Fund277KUS$22.2MJul 31, 2026
Schwab U.S. Small-Cap ETF263KUS$19.4MMay 31, 2026
iShares U.S. Medical Devices ETF257KUS$21.2MJun 30, 2026
U.S. Small Cap Portfolio240KUS$19.2MJul 31, 2026
U.S. Targeted Value Portfolio239KUS$19.2MJul 31, 2026
Dimensional U.S. Targeted Value ETF207KUS$16.6MJul 31, 2026
Nuveen Quant Small Cap Equity Fund202KUS$16.2MJul 31, 2026
SmallCap Growth Fund I199KUS$15.9MJul 31, 2026
Hood River New Opportunities Fund189KUS$15.6MJun 30, 2026
Dimensional U.S. Small Cap ETF183KUS$14.7MJul 31, 2026
Vanguard Explorer Fund183KUS$14.7MJul 31, 2026
Emerald Growth Fund181KUS$14.5MJul 31, 2026
Emerald Growth Fund181KUS$10.9MApr 30, 2026
U.S. Micro Cap Portfolio178KUS$14.3MJul 31, 2026
JPMorgan Small Cap Blend Fund172KUS$14.2MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account170KUS$14MJun 30, 2026
Vanguard Health Care Index Fund164KUS$12.1MMay 31, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund153KUS$12.3MJul 31, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund153KUS$11.3MMay 31, 2026
Victory Integrity Small-Cap Value Fund150KUS$12.3MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund146KUS$12MJun 30, 2026
Fidelity Small Cap Discovery Fund145KUS$11.6MJul 31, 2026
Columbia Select Small Cap Value Fund143KUS$10.5MMay 31, 2026
Fidelity Small Cap Growth K6 Fund140KUS$11.2MJul 31, 2026
Schwab Small-Cap Index Fund137KUS$10.9MJul 31, 2026

This page holds 50 of 391 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Shvartsburg Alex
Officer: Chief Financial Officer
Sale2,500USD 90.91US$227KNov 12, 2026
Bianchi Francesco
Director
Sale3,500USD 78.01US$273KSep 10, 2026
Story Brooke
Director
Sale2,300USD 81.42US$187KSep 4, 2026
Bianchi Francesco
Director
Sale1,650USD 79.72US$132KAug 31, 2026
Tezel Ahmet
Officer: Chief Innovation Officer
Sale2,675USD 77.74US$208KAug 11, 2026
Bianchi Francesco
Director
Sale1,200USD 80.19US$96,228Jun 15, 2026
Bianchi Francesco
Director
Sale1,800USD 75.75US$136KMay 26, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andrea Lynn Saia
Other companies: Outset Medical, Inc. (Director · Since at least Mar 23, 2021); Align Technology, Inc. (Director · Since at least Jul 25, 2013); Coca-Cola Enterprises Inc (Director · Jun 7, 2012 – Mar 31, 2016 · Past)
Director · Jul 27, 2016 – Dec 31, 2023 · Past
Donald Zurbay
Other companies: Sight Sciences, Inc. (Director · Since at least Jun 4, 2026); Dentsply Sirona Inc. (Director · Since at least Jan 13, 2026)
Director · Since at least Sep 4, 2025
Susan Podlogar
Other companies: Tevogen Bio Holdings Inc. (Director · Since at least Feb 14, 2024); MetLife, Inc. (EVP & Chief HR Officer · Dec 20, 2022 – Mar 1, 2024 · Past)
Director since 2024 · Since at least Oct 8, 2024
William Kozy
Other companies: The Cooper Companies, Inc. (Director · Apr 1, 2016 – Apr 1, 2025 · Past); Becton, Dickinson and Company (Executive Vice President · Jan 27, 2006 – Dec 9, 2015 · Past)
Chair of the Board · Since at least Jun 12, 2018
David S Wise
Other companies: Cyberonics Inc (SR VP & Chief Admin Officer · Jun 8, 2009 – Oct 19, 2015 · Past)
Chief Administrative Officer · Oct 19, 2015 – Jan 15, 2019 · Past
Thad Huston
Other companies: Artiva Biotherapeutics, Inc. (Chief Financial Officer and Award of Inducement Grant · Since at least Feb 18, 2026)
Chief Financial Officer · May 20, 2017 – May 23, 2020 · Past
Todd C. Schermerhorn
Other companies: The Travelers Companies, Inc. (Director · Since at least Feb 4, 2020)
Director since 2020 · Since at least Dec 2, 2020
Ahmet TezelChief Innovation Officer · Since at least May 13, 2024
Alex ShvartsburgChief Financial Officer · Since at least Apr 1, 2026
Anne LiddyChief Legal Officer · Since at least Jun 5, 2026
All 33 people
PersonSeat
Briana GotlinVice President, Investor Relations · Since at least May 6, 2026
Brooke StoryDirector since 2022 · Since at least Jun 11, 2026
Daniel Jeffrey MooreDirector · Jun 3, 2024 – Jun 3, 2024 · Past
Deanna WilkeVP, Corporate Communications · Since at least Jun 11, 2026
Francesco BianchiDirector since 2015 · Since at least Jun 11, 2026
Franco PolettiPresident, Cardiopulmonary · Since at least Aug 1, 2024
James Christopher BarryDirector · Since at least Oct 6, 2023
J. Christopher BarryDirector since 2023 · Since at least Nov 5, 2026
Jette Nygaard-AndersenDirector since 2026 · Since at least Jun 11, 2026
Lucile BlaiseGlobal Head of Commercialization, Obstructive Sleep Apnea · Since at least Dec 2, 2025
Michel DarnaudPresident Cardiac Surgery · Oct 19, 2015 – Jul 27, 2016 · Past
Natalia KozminaChief Human Resources Officer · Since at least Jan 6, 2025
Peter WilverDirector · Since at least Jun 11, 2026
Philip KowalczykChief Strategy and Corporate Development Officer · Since at least Sep 3, 2026
Rosario BifulcoDirector · Oct 19, 2015 – Oct 19, 2015 · Past
Roy KhouryPresident, International · Jan 10, 2020 – Mar 1, 2021 · Past
Seng Stacy EnxingDirector · Since at least Jun 15, 2022
Stacy Enxing SengDirector since 2019 · Since at least Jun 11, 2026
Stefano Di LulloPres Cardiac Rhythm Mgmt · Oct 19, 2015 – Jul 27, 2016 · Past
Stefano FolliPresident, Cardiopulmonary · Since at least May 21, 2026
Stephanie BoltonPresident, Global Epilepsy · Since at least Mar 1, 2024
Sujay MashruSenior Vice President, APAC and Growth Markets · Since at least Nov 5, 2026
Vladimir MakatsariaChief Executive Officer, Director · Since at least Mar 1, 2024

Open People

Log in to ask 6ix AI your own questions about LivaNova PLC.